Catalyst Wire Dossier Catalyst Wire Dossier

TEPADINA

THIOTEPA · Amneal Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for TEPADINA, covering 2017-01-26 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma:A Prospective Randomized Controlled Clinical Trial [NA]

See pricing